NFID

NFID Announces 2024 Recipients of Prestigious Awards

Retrieved on: 
Tuesday, April 9, 2024
RN, Maxwell Finland Award, COVAX, Health equity, HIV, Biomedical Research, Health, Patient, Epidemic, Infection, Rockefeller Foundation, Vaccine, Ageing, AIDS, International, Education, Policy, Master of Science, Woman, Gavi, World Health Organization, Immunization, Safety, Disease, Global health, Public, Research, Death, Mentorship, NFID, MPH, National Academy of Medicine, CPNP, COVID-19, IAVI, National academy, Developed country

BETHESDA, Md., April 9, 2024 /PRNewswire/ -- The National Foundation for Infectious Diseases (NFID) has announced the 2024 recipients of the prestigious NFID awards honoring outstanding individuals who have made significant and lasting contributions to public health through leadership, scientific achievement, philanthropy, and policy work. The following awards will be presented at the 2024 NFID Awards Gala in Washington, DC in September 2024:

Key Points: 
  • BETHESDA, Md., April 9, 2024 /PRNewswire/ -- The National Foundation for Infectious Diseases (NFID) has announced the 2024 recipients of the prestigious NFID awards honoring outstanding individuals who have made significant and lasting contributions to public health through leadership, scientific achievement, philanthropy, and policy work.
  • The following awards will be presented at the 2024 NFID Awards Gala in Washington, DC in September 2024:
    Seth F. Berkley, MD, of the Pandemic Center of Brown University, will receive the 2024 Jimmy and Rosalynn Carter Humanitarian Award in recognition of his work as an innovative entrepreneur, a pioneer in global health, and a champion of equitable access to vaccines.
  • The awards will be presented at the 2024 NFID Awards Gala and Silent Auction, a black-tie fundraising event scheduled for September 19, 2024, in Washington, DC.
  • All contributions support the NFID mission to educate the public and healthcare professionals on the prevention and treatment of infectious diseases.

Experts Urge Vaccination as Measles Cases Rise

Retrieved on: 
Tuesday, March 5, 2024
Infection, NFID, RN, News, Pneumonia, Immunodeficiency, Vaccination, Vaccine, Vitamin A, Death, Brain damage, MPH, MMR, Disease, Immunity, CPNP, Measles vaccine, Seizure, Public

With measles cases on the rise, experts are urging everyone to make sure they are up to date on vaccination.

Key Points: 
  • With measles cases on the rise, experts are urging everyone to make sure they are up to date on vaccination.
  • Measles was declared eliminated in the US in 2000, but cases still occur when international travelers who get measles overseas bring it into the US or as cases spread in US communities with pockets of unvaccinated people.
  • Severe measles cases among children, including those who are hospitalized, may be treated with vitamin A, according to an NFID report on Vitamin A for the Management of Measles in the US .
  • NFID experts are available to talk about measles, the recent increase in cases in the US, the importance of measles vaccination as recommended, and treatment with vitamin A for severe cases.

Phreesia Joins Call to Action to Improve Adult Vaccination Rates

Retrieved on: 
Tuesday, January 23, 2024
COVID-19, Technology, Human Resources, Public Relations, Investor Relations, Communications, Professional Services, Software, General Health, Pharmaceutical, Health, Death, Patient, Heart, MD, NFID, Diphtheria, American Pharmacists Association, Tetanus, American Medical Association, Vaccination, Disability, Infection, DPT vaccine, Cardiovascular disease, Immunization, Organization, HPV, National Forum, Vaccine, RSV

Phreesia, a leader in patient intake, outreach and activation, is pleased to announce that it has joined the National Adult and Influenza Immunization Summit’s Call to Action for Adult Immunizations campaign to improve adult vaccination rates.

Key Points: 
  • Phreesia, a leader in patient intake, outreach and activation, is pleased to announce that it has joined the National Adult and Influenza Immunization Summit’s Call to Action for Adult Immunizations campaign to improve adult vaccination rates.
  • More than three in four adults are missing routinely recommended vaccines and, due to preventive care put on hold during the COVID-19 pandemic, low vaccination rates have worsened.
  • The mission of the campaign is to encourage healthcare providers to take action to improve the implementation of adult vaccination recommendations to protect adults from preventable illness, disability and death.
  • Within the last few years, Phreesia has delivered over 20.7 million messages to adults to encourage conversations with care teams about recommended vaccines.

This Week in Health News: 10 Stories You Need to See

Retrieved on: 
Friday, December 1, 2023
X-ray, CTS, Transesophageal echocardiogram, Health equity, Bristol Myers Squibb, Research, Magnetic resonance imaging, Bank, Nicklaus Children's Hospital, Kohl's, Cardiology, Cost Plus Drugs, Award, Avidity, Database, CAA, Related, Vaccine, Hostess, Infection, Rehabilitation, NFID, NAMI, Grace, Pharmacy, Burns, MPH, Geography, Subject-matter expert, Survivor, Mental health, PR Newswire, Creative Artists Agency, Bank of America, News, Environment, Nextgen, Nursing, Pharmaceutical industry, Publishing, Adobe, MD, Boeing

NEW YORK, Dec. 1, 2023 /PRNewswire/ -- With thousands of press releases published each week, it can be difficult to keep up with everything on PR Newswire. To help journalists covering the healthcare industry stay on top of the week's most newsworthy and popular releases, here's a roundup of stories from the week that shouldn't be missed.

Key Points: 
  • Together, we're reshaping the narrative around drug costs, setting a new industry standard."
  • "We are excited to expand our collaboration with Bristol Myers Squibb, who are world leaders in cardiovascular drug discovery and development.
  • Subject Matter Experts: Access ProfNet , a database of industry experts to connect with as sources or for quotes in your articles.
  • Related Resources: Read and subscribe to our journalist- and blogger-focused blog, Beyond Bylines , for media news roundups, writing tips, upcoming events, and more.

NFID Calls for 2024 Awards Nominations Honoring Public Health Heroes

Retrieved on: 
Wednesday, November 29, 2023
Health equity, Policy, Epidemiology, Organization, Infection, Award, Vaccine, NFID, Carter Center, MPH, Diagnosis, Democracy, Maxwell Finland, Public, Pharmaceutical industry, MD

BETHESDA, Md., Nov. 29, 2023 /PRNewswire/ -- The National Foundation for Infectious Diseases (NFID) is calling for nominations for the 2024 annual awards to honor public health heroes who have made significant and lasting contributions to global public health through scientific achievement, philanthropy, and policy work.

Key Points: 
  • BETHESDA, Md., Nov. 29, 2023 /PRNewswire/ -- The National Foundation for Infectious Diseases (NFID) is calling for nominations for the 2024 annual awards to honor public health heroes who have made significant and lasting contributions to global public health through scientific achievement, philanthropy, and policy work.
  • NFID is now accepting nominations for:
    Named for former President and the late Mrs. Carter, the award honors individuals whose outstanding humanitarian efforts and achievements have contributed significantly to improving global public health through domestic and/or international activities.
  • Nominees must be living at the time of nomination and selected recipients must agree to attend the NFID Awards Gala in Washington, DC in September 2024 to receive the award.
  • Current members of the NFID Board of Directors are not eligible for nomination and self-nominations will not be accepted.

3 Things To Know on World Pneumonia Day

Retrieved on: 
Thursday, November 9, 2023
National Foundation for Infectious Diseases, Streptococcus, Fungal infection, Respiratory failure, Attenuated vaccine, Vaccine, American Lung Association, MD, NFID, HIV, Diabetes, Sickle cell disease, Kidney, Fever, Cough, Chest pain, Vaccination, Disease, Risk, Immune system, COVID-19, Asthma, Chills, Infection, Sepsis, Diagnosis, Death, Pneumonia

In support of World Pneumonia Day on November 12, NFID and the American Lung Association are working to raise awareness about pneumococcal disease and encourage those who are at risk to talk with a healthcare professional about pneumococcal vaccination.

Key Points: 
  • In support of World Pneumonia Day on November 12, NFID and the American Lung Association are working to raise awareness about pneumococcal disease and encourage those who are at risk to talk with a healthcare professional about pneumococcal vaccination.
  • Here are 3 things to know on World Pneumonia Day:
    Anyone can get pneumonia, but some people are at higher risk.
  • "Even healthy adults over 65 years are at increased risk for pneumococcal pneumonia, because the body's immune system naturally weakens with age.
  • "Fortunately, pneumococcal pneumonia vaccines are available to help prevent the disease."

US Health Officials Urge Vaccination Against Flu, COVID-19, and RSV This Fall and Winter

Retrieved on: 
Thursday, September 28, 2023
Vaccine, United Nations Foundation, Infection, National Foundation for Infectious Diseases, Tulane University School of Medicine, Pregnancy, Streptococcus, Hopkins, Diabetes, Education, Vaccination, Hospital, COVID-19, Woman, Medicine, Pharmacy, Doctor of Philosophy, MS, CDC, Death, CPNP, RSV, Mask, Risk, Patient, Korea Disease Control and Prevention Agency, Brace, Immune system, Schaffner, RN, Health, Cardiology, MPH, White, News, Kidney disease, NFID, Pharmaceutical industry, MD

BETHESDA, Md., Sept. 28, 2023 /PRNewswire/ -- As the US braces for the upcoming fall and winter virus season, new survey data released today by the National Foundation for Infectious Diseases (NFID) show that despite the potential severity, only 22% of US adults are worried about themselves or someone in their family getting infected with influenza (flu), with similar low levels of concern about COVID-19 (23%) and respiratory syncytial virus (RSV) (19%) infection. The data also show that although nearly two-thirds of US adults (65%) agree that vaccination is the best preventive measure against flu-related hospitalizations and deaths, 43% of US adults do not plan to or are unsure if they will get vaccinated against flu. Although updated COVID-19 vaccines are recommended, only 40% plan to get vaccinated against COVID-19, and among adults age 60 years and older, only 40% plan to get vaccinated against RSV.

Key Points: 
  • We must use all available tools to protect those most at risk, including infants and young children, pregnant people, older adults, and those with chronic health conditions."
  • "The NFID data—which show complacency around vaccination against flu, COVID-19, RSV, and pneumococcal disease—are concerning," said NFID President Patricia (Patsy) A. Stinchfield, RN, MS, CPNP.
  • "Even in cases when vaccination does not prevent infection entirely, getting vaccinated can help protect against serious complications, including hospitalization and death."
  • "Flu season is a great time to ask about pneumococcal vaccination because pneumococcal disease can be a serious complication of flu."

NFID Celebrates 50th Anniversary with Gala Honoring Public Health Heroes

Retrieved on: 
Wednesday, August 23, 2023
Vaccine, National Foundation for Infectious Diseases, CAE, PE, Vaccine-preventable diseases, Doctor of Pharmacy, Education, Medical college, COVID-19, Infection, Hepatitis B, Human, Research, History, Doctor of Philosophy, Respiratory syncytial virus, Bangladesh Technical Education Board, MS, CDC, Organization, CPNP, Pharmacist, RSV, National Immunization Technical Advisory Group, Nursing, Korea Disease Control and Prevention Agency, Cystic fibrosis, Schaffner, Duma, RN, MPH, Immunization, Conference, News, NFID, Pharmaceutical industry, MD

BETHESDA, Md., Aug. 23, 2023 /PRNewswire/ -- Today marks the 50th anniversary of the establishment of the National Foundation for Infectious Diseases (NFID) which will be commemorated with an elegant 50th Anniversary Gala in Washington, DC on September 14, 2023.

Key Points: 
  • BETHESDA, Md., Aug. 23, 2023 /PRNewswire/ -- Today marks the 50th anniversary of the establishment of the National Foundation for Infectious Diseases (NFID) which will be commemorated with an elegant 50th Anniversary Gala in Washington, DC on September 14, 2023.
  • Celebrating 50 years of education, prevention, and impact, the gala will recognize the work of NFID and the inspirational public health heroes who have helped protect the lives of millions.
  • NFID supporters and public health luminaries will gather in Washington, DC to celebrate the remarkable history and notable accomplishments at the NFID 50th Anniversary Gala on September 14, 2023.
  • An NFID 50th Anniversary Commemorative Book that looks back at the history of NFID and celebrates the trailblazing efforts of NFID leaders and public health heroes over the past 5 decades is also available for purchase online.

NFID Names Robert H. Hopkins, Jr., MD, as Medical Director

Retrieved on: 
Thursday, July 20, 2023
Vaccine, National Foundation for Infectious Diseases, Immunization, CAE, University, Hopkins, Education, Internal medicine, Human services, Public, Pediatrics, University of Arkansas for Medical Sciences, Advisory Committee, Medicine, UAMS, Human, Infection, Advisory Committee on Immunization Practices, Korea Disease Control and Prevention Agency, Growth, American College, NFID, Pharmaceutical industry, Management, Nursing, MD

BETHESDA, Md., July 20, 2023 /PRNewswire/ -- The National Foundation for Infectious Diseases (NFID) has announced the appointment of Robert H. Hopkins, Jr., MD, as its new medical director.

Key Points: 
  • BETHESDA, Md., July 20, 2023 /PRNewswire/ -- The National Foundation for Infectious Diseases (NFID) has announced the appointment of Robert H. Hopkins, Jr., MD, as its new medical director.
  • Hopkins succeeds William Schaffner, MD, who served NFID for many years and will continue to serve as an NFID spokesperson, lending his expertise to NFID initiatives.
  • As medical director, Hopkins will focus on the growth of NFID programs, including efforts to build vaccine confidence, address health equity issues, increase awareness of disease prevention and treatment, and strengthen NFID partner collaborations.
  • In his role as NFID medical director, Hopkins will also serve as an ex-officio member of the NFID Board of Directors and all Board-level committees.

LONGEVITY TO BE SHOWCASED ON NATIONALLY SYNDICATED TAMRON HALL SHOW, BROOKE BURKE WILL APPEAR TO DISCUSS LONGEVITY SUPER FOOD IN TWO SEGMENTS.

Retrieved on: 
Tuesday, November 15, 2022
People, Tamron Hall, Human, Health, Social media, Brooke, Forward-looking statement, Star, Organic certification, Dance, CAGR, Business, Forbes, Longevity, Season, Ministry of Health & Wellness, Women's Health (magazine), NFID, USD, Brand, OTC, LIVE, Daytime Emmy Awards, Mobile phone

Known as Syndications most upscale talk show, the Tamron Hall show has over 16,000,000 monthly viewers.

Key Points: 
  • Known as Syndications most upscale talk show, the Tamron Hall show has over 16,000,000 monthly viewers.
  • Longevity will be featured in two segments where Brooke will discuss Longevity and its benefits.
  • People can learn more by clicking this link: Tuesday 11.15.2022 Tamron Hall Show
    Tamron Hall is a Two-time Emmy-winning journalist, author and producer - Tamron Hall is executive producer and host of the nationally syndicated talk show "Tamron Hall," which is in it's fourth.
  • About Brooke Burke and Brooke Burke Body:
    Brooke Burke holds many titles including mother of four, author, cancer survivor, entrepreneur, fitness educator, philanthropist and television personality.